Publication | Open Access
Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
14
Citations
29
References
2022
Year
Solriamfetol 300 mg/day significantly improved on-the-road driving performance in participants with EDS associated with OSA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1